Artificial Intelligence | Machine Learning | Machine Perception Great Bay Bio | AI-enabled Bioprocessing


Enterprise, Biotechnology, Biopharmaceutical, Data Analytics, Drug Research Hong Kong Island , Hong Kong, Hong Kong

Great Bay Bio

Artificial Intelligence | Machine Learning | Machine Perception


Great Bay Bio | AI-enabled Bioprocessing

Great Bay Bio

Biotechnology, Biopharmaceutical, Data Analytics, Drug Research


Hong Kong Island , Hong Kong, Hong Kong

Greater Bay Bio is a high-tech enterprise. Which is on a mission of applying AI and advanced technologies for the development of biopharmaceuticals and other Blue-ocean Bio-products. Its aim is to solve the main problems of this sector which include High-Failure Rates, a Long Development Timeline, and High Costs. GBB has researched and developed a number of Bio-logic products at the NDA stage, few of them are also classified as National Class-1 Innovative Drugs

Headquartered in Hong Kong, Great Bay Bio (GBB) is a high-tech enterprise dedicated to applying artificial intelligence and other cutting-edge technologies to the development of biopharmaceuticals and other blue ocean bio-products. GBB aims to ultimately solve numerous pain-points found in the biopharmaceutical industry, including high failure rates, long development timeline and high costs. Since establishment, the company has obtained massive drug development data from its 3100 m2 international level CMC facility. Prior, GBB has successfully brought a number of biologic products to NDA stage, some of which are classified as national class I innovative drugs. Currently, the company has created an intelligent centralized database, where deep learning is being performed to create a next generation AI-enabled bioprocessing ecosystem. Combining cutting-edge AI technology and years of experience in drug research and development, GBB has successfully developed a series of intelligent bioprocessing platforms since 2019. Currently, Klone4.0TM (AI-enabled cell line development platform), AlfaStaXTM (AI-enabled cell line stability prediction platform) and AlfaMedX® (AI-enabled culture media development platform) are commercially available..

 

B2B

101 to 250

Series B

$27.5M

Scaling Up

2019

 
 

Pharmaceuticals
Biotechnology

Reduced Development Costs

Increase Efficiency

 
 

Analytics
Service

Yes

Active

 
 

   Machine Learning
   Machine Perception


Biotechnology

Biotechnology


Image

Image

Video

Video

Text

Text

Structured

Structured

 

   Software


JavaScript

JavaScript

C/C++

C/C++

Docker

Docker

Python

Python

Flink

Flink

Node.js

Node.js

Typescript

Typescript

Redux

Redux


Machine Learning Algorithm

Machine Learning Algorithm

Deep Learning Algorithm

Deep Learning Algorithm

 
 

Aug 2022

  • GBB Was Listed on 2022 Spring Semester of Microsoft Acceleration Program

Jan 2022

  • Great Bay Bio Forged Strategic Alliance with Cheerland Life Science

Sep 2021

  • Kingsley awarded Gen,T Social Impact and Leader of tomorrow award 2021

Aug 2021

  • GBB listed in Top 15 of 2021 by Merck Greater Bay Area Bootcamp

Jul 2021

  • GBB and Chime Biologics Partner

Jul 2021

  • GBB Launched AlfaStax

Mar 2021

  • GBB Launched AlfaMedX
 
 

View All

Marketing Director

Remote, Remote

 

AI/ML Professionals

Want to work at Great Bay Bio?

We can introduce you to the right person at Great Bay Bio

Talk to our Talent Team

 

7

2

$12.5M

Company was founded 2019 and it took almost 2 years (Dec 2021) to raise first external round

 
 

Date

Round

$ Raised

Investors

09/15/2022

Series A

$15M

Tiger Jade Capital, AEF Greater Bay Area Fund, Vectr Ventures, Gobi Partners, Alibaba Entrepreneurs Fund, Alon Capital

Date : 09/15/2022

Round: Series A

$ Raised: $15M

Investors: Tiger Jade Capital, AEF Greater Bay Area Fund, Vectr Ventures, Gobi Partners, Alibaba Entrepreneurs Fund, Alon Capital

12/01/2021

Series A

$10M

Proxima Ventures

Date : 12/01/2021

Round: Series A

$ Raised: $10M

Investors: Proxima Ventures

 

Investors

Interested in researching Great Bay Bio?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Great Bay Bio

Request a Demo - Deal Souring Platform

 
Xinyu (Sean) Deng


Xinyu (Sean) Deng
Chief Technology Officer

Michael Chen


Michael Chen
CEO

 Kingsley Leung


Kingsley Leung
Chairman and Co-Founder

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Great Bay Bio